Endocrine Abstracts

The aim: To evaluate the results of Questionnaire by Comprehensive Symptom Profile Diabetes Mellitus hypoglycemia (CSP-DM-HypoGl) nodule in type 2 diabetes patients

Material and methods: Under our supervision in the departments of the Center of Endocrinology of PH Ministry of RUz in the period from September 2016 for December, to 2017, 20 patients were observed with DM 2, men – 9, women-11; 54.5±1.5 m/61,6±1.8 w years old. The remoteness of disease hesitated in limits from 7 to 9 years. All patients were observed by standard rules.

Results: Patients were distributed on 2 groups: 1 gr – 10 patients (5/5), which received IIT, 2 gr – 10 patients (4/6) on CT (insulin + Metformin, SM, etc). We studied results of CSP-DM-HypoGl in all patients, which has 28 questions. On the data of interpretation of CSP-DM-HypoGl, if patients results achieve 1–4 in middle: this is lower degree of hypoglycemia, if 5-6 – middle degree of hypoglycemia and 7 >: higher degree of hypoglycemia. In 1 st group of patients we found of CSP-DM-HypoGl in range of 7±0.3, which submit higher degree of episodes of hypoglycemia in this group. Patients had such symptoms as weakness, headache, disorders of sleep. In the 2 nd group of patients we found middle range of CSP-DM-HypoGl 5,5±0.4, which submit middle degree of episodes of hypoglycemia in this group.

Conclusions: The using of CSP-DM-HypoGl gives possibility to evaluate the degree of symptomatic hypoglycemia in patients with DM 2